Avion Pharma is in a tricky position.
The drugmaker has been under pressure to improve its earnings.
But it has also struggled with rising costs.
Avion has been losing money on revenue, and this year it plans to raise its price, raising the possibility that Avion’s earnings could fall.
The stock is also under pressure from its own shareholders.
But as it prepares to release its second-quarter results later this month, Avion says it will also report better-than-expected results.
Avions earnings are likely to fall, but it is also likely to improve Avions share price.
What you need to know about Avion, its drugs and how it stacks up to other stocks in this space.